Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators.

McGuire, D K; Emanuelsson, H; Granger, C B; Magnus Ohman, E; Moliterno, D J; White, H D; Ardissino, D; Box, J W; Califf, R M; Topol, E J

McGuire, D K; Emanuelsson, H; Granger, C B; Magnus Ohman, E; Moliterno, D J; White, H D; Ardissino, D; Box, J W; Califf, R M; Topol, E J.

Affiliation

McGuire DK; The Duke Clinical Research Institute, Durham, North Carolina 27715, USA.

Eur Heart J ; 21(21): 1750-8, 2000 Nov.

Article in En | MEDLINE | ID: mdl-11052839

Subject(s)

Diabetes Mellitus, Type 1/drug therapy; Diabetes Mellitus, Type 1/epidemiology; Heparin/administration & dosage; Hirudins/administration & dosage; Myocardial Infarction/drug therapy; Myocardial Infarction/epidemiology; Aged; Comorbidity; Confidence Intervals; Diabetes Mellitus, Type 1/diagnosis; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction/diagnosis; Odds Ratio; Probability; Reference Values; Risk Assessment; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Heparin / Hirudins / Diabetes Mellitus, Type 1 / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Heart J Year: 2000 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links